RESUMEN
BACKGROUND: Ameloblastoma is a common locally invasive but slow-growing neoplasm of the jaws with an odontogenic origin. Association between BRAF V600E mutation and clinicopathologic features and behavior of ameloblastoma remains controversial. This study aimed to evaluate BRAF V600E gene mutation and expression of its related proteins with clinicopathologic parameters in conventional ameloblastoma. MATERIAL AND METHODS: 50 Formalin-fixed paraffin-embedded blocks were included in this study. Immunohistochemistry was done using rabbit monoclonal BRAF V600E mutation-specific antibody VE1. Quantitative real-time polymerase chain reaction assay was used for evaluating of BRAF V600E mutation. RESULTS: Expression of BRAF V600E antibody was Positive in 42 out of 50 cases (84%). 46 (92%) out of 50 specimens showed BRAF V600E mutation. There were 13 cases of recurrence (26%). 3 out of 4 cases with negative mutations did not show recurrence. CONCLUSIONS: We report the highest frequency (92%) of BRAF V600E mutation in ameloblastomas in the Iranian population. Although there was not a significant association between BRAF V600Epositive immunoexpression and recurrence and clinicopathologic parameters, its high frequency could emphasize its role as a therapeutic marker in the future.
Asunto(s)
Ameloblastoma , Biomarcadores de Tumor , Humanos , Irán , Mutación , Recurrencia Local de Neoplasia , Proteínas Proto-Oncogénicas B-raf/genéticaRESUMEN
BACKGROUND: Biliary tract cancer (BTC) is a malignancy characterized by a low 5-year survival rate (<20â¯%). Clinical aspects such as tumor resectability, Eastern Cooperative Oncology Group performance status score (ECOG-PS), and molecular profiling are used to determine the treatment for these patients. Diagnosis and treatment are typically established by a multidisciplinary team (MDT). However, standardized practices for BTC are lacking, and there is a need to assess the impact of current MDT treatment decisions on BTC outcomes. The purpose of this study was to investigate the role of the treatment plan proposed by the first MDT conference on survival in patients with BTC, and to identify risk factors for poor survival in this population. METHOD: This nationwide, multicenter, retrospective cohort study examined data from the Danish Liver Cancer Group (2013-2020) with confirmed BTC diagnoses. Multiple imputation was used to handle missing data. Survival and variable-survival rate relationships were analyzed using the Kaplan-Meier estimator, and the Cox regression model, respectively. RESULTS: Eligible BTC-confirmed cases: n=1923. The overall median survival was 7.7 months (95â¯% CI: 7.1-8.5), with a 5-year survival rate of 16.3â¯%. Patients over 70 years of age, with ECOG-PS 3 or 4, non-operable cases, and with unresectable tumors had lower survival rates. Surgery as the first therapeutic option showed the highest median survival (33.1 months, 95â¯% CI: 27.2-41.6; p < 0.0001). Multivariable analysis showed that poor ECOG-PS, palliative and neoadjuvant chemotherapy, stereotactic radiotherapy, and best supportive care significantly increased mortality risk in patients with BTC (p=0.05). CONCLUSION: Among the therapeutic options prescribed by the MDT for patients with BTC, surgery offered the best survival rates, likely due to patient-related prognostic factors. High ECOG-PS was linked to an increased mortality risk regardless of age, highlighting the importance of this criterion in treatment decisions.
RESUMEN
Although gastresophageal reflux disease (GERD) is highly prevalent in Western countries, we have very little data about it in African countries. The aim of the study is to determine the prevalence and severity of GERD symptoms among Tunisian subjects and report its characteristics, consultation rate, management modes, as well as patients' satisfaction. Five hundred subjects living in Tunisia were interviewed face to face. The study was conducted at seven centers of primary care at Monastir's department by six interviewer doctors. The questionnaire consisted of 30 questions relating to subject attributes, lifestyle factors, medical history, reflux-related symptom characteristics, consultation behavior, previous treatments for GERD, and description of the last episode. Symptoms were defined as 'frequent' if they occurred at least weekly and 'occasional' if they occurred less frequently during the last year. The mean age was 42.3 ± 17.3 years and 75.6% were females. Over the previous year, 60% of the respondents reported suffering any GERD symptom. The prevalence of frequent GERD is 24%. Female gender (odds ratio [OR]: 1.97[1.15-3.37]) and body mass index ≥ 25 (OR: 1.54[1.042-2.29]) were associated with increased risk of GERD symptom. Only 22.3%, sought medical advice about GERD symptoms in the last year. In the univariate and multivariate analysis, work status, frequency and intensity of symptoms, duration of symptom, and association of atypical symptoms were associated with a higher frequency of medical consultation for GERD symptoms. Among the subjects complaining about heartburn, 34% took medications. GERD symptoms are common among Tunisian subjects. Few heartburn sufferers seek medical attention, and most do not take medications for symptomatic control.
Asunto(s)
Reflujo Gastroesofágico/epidemiología , Aceptación de la Atención de Salud/estadística & datos numéricos , Atención Primaria de Salud/estadística & datos numéricos , Adolescente , Adulto , Anciano , Índice de Masa Corporal , Empleo , Femenino , Reflujo Gastroesofágico/complicaciones , Pirosis/tratamiento farmacológico , Pirosis/etiología , Humanos , Entrevistas como Asunto , Modelos Logísticos , Masculino , Persona de Mediana Edad , Análisis Multivariante , Prevalencia , Índice de Severidad de la Enfermedad , Factores Sexuales , Túnez/epidemiología , Adulto JovenRESUMEN
BACKGROUND: The aim of this study was to determine the prevalence and clinical spectrum of gastroesophageal reflux disease (GERD) in Tunisia and to compare the characteristics and disease management of subjects complaining of at least weekly and less frequent gastroesophageal reflux symptoms. METHODS: Five hundred subjects living in Tunisia were interviewed face to face. The questionnaire consisted of 30 questions relating to subject attributes, lifestyle factors, medical history, reflux-related symptom characteristics, consultation behavior, previous treatments for GERD and description of the last episode. RESULTS: The mean age was 42.3±17.3 years and 75.6% were females. Sixty percent of the responders reported at least one GERD symptom. The prevalence of frequent GERD was 24%. Only 22.3% had sought medical advice about GERD symptoms in the last year. Of those who had consulted, 75% of individuals waited over 6 months before consulting a physician. Compared with subjects with occasional gastroesophageal reflux symptoms, those with frequent symptoms suffered from more severe symptoms, (OR: 3.5; CI 95%: 1.9-6.4), had more often sought medical advice (OR: 2.9 CI 95%: 1.6-5.2) and had more often used a drug therapy for GERD (OR: 2.2; CI 95%:1.3-3.8). In the multivariate analysis, work status, frequency and intensity of symptoms, duration of symptoms and association of atypical symptoms were associated with a higher frequency of medical consultation for GERD symptoms. CONCLUSION: GERD symptoms are common in the Tunisian population. The population with frequent GERD exhibits more severe symptoms and greater healthcare use.
Asunto(s)
Reflujo Gastroesofágico/diagnóstico , Reflujo Gastroesofágico/epidemiología , Adolescente , Adulto , Anciano , Estudios Transversales , Femenino , Humanos , Masculino , Persona de Mediana Edad , Prevalencia , Adulto JovenRESUMEN
This study was conducted to assess the roles of maternal measles-rubella (MR) vaccination before pregnancy on the persistence of passive immunity against MR in their infant before measles-mumps-rubella (MMR) immunization and the effects on the immunogenicity of MMR vaccine. Before and 4-8 weeks after MMR immunization of all healthy 12-month-old infants, sera samples were prepared. According to their mother's history of MR vaccination, infants were divided into two groups. Anti-MR antibodies were measured by the quantitative enzyme-linked immunosorbent assay (ELISA) method. The difference in seroconversion rates and the mean concentration of antibodies (MCA) between the two groups of infants were analyzed by descriptive statistical methods. In total, 7 and 12 sera, all from infants born from MR-vaccinated mothers, were positive against measles and rubella, respectively. The seroconversion rates were 90.5 and 53% in seronegative infants against measles and rubella, respectively, without statistically significant differences between the two groups of infants. However, the MCA differences were significant; measles P = 0.000, rubella P = 0.019. The MR vaccination of mothers may cause the prolongation of passive immunity in their infants, and may influence the immunogenicity of MMR vaccination. This finding should be considered for the optimal scheduling of the first dose of MMR vaccine. Also, the results showed that the immunogenicity of the rubella component of the MMR vaccine was lower than that reported.
Asunto(s)
Vacuna contra el Sarampión-Parotiditis-Rubéola/inmunología , Sarampión/prevención & control , Paperas/prevención & control , Rubéola (Sarampión Alemán)/prevención & control , Adulto , Anticuerpos Antivirales/sangre , Ensayo de Inmunoadsorción Enzimática , Femenino , Humanos , Inmunidad Materno-Adquirida , Esquemas de Inmunización , Lactante , Masculino , Sarampión/inmunología , Paperas/inmunología , Rubéola (Sarampión Alemán)/inmunología , Adulto JovenRESUMEN
Treatment of chronic hepatitis C virus (HCV) infection in transfusion-dependent beta-thalassaemia major patients is complicated by existing hepatic siderosis and the fear of ribavirin-associated haemolysis. We evaluated the efficacy and side-effects of combination interferon-alpha (INF) and ribavirin therapy for HCV-infected thalassaemia patients. A total of 17 patients were enrolled (10 nonresponders to INF monotherapy, 7 naive to treatment, mean age 23.1 years) and they received 12 months of combination therapy. The sustained virological response rate 6 months after treatment was 58.8%. Blood transfusion requirements during treatment temporarily increased by 36.6%. Combination therapy was tolerated by, and may be useful for, HCV-infected thalassaemia major patients.
Asunto(s)
Antivirales/uso terapéutico , Hepatitis C Crónica/complicaciones , Hepatitis C Crónica/tratamiento farmacológico , Interferón Tipo I/uso terapéutico , Ribavirina/uso terapéutico , Talasemia beta/complicaciones , Adolescente , Adulto , Alanina Transaminasa/sangre , Biopsia , Transfusión Sanguínea/estadística & datos numéricos , Monitoreo de Drogas , Quimioterapia Combinada , Femenino , Ferritinas/sangre , Hemosiderosis/etiología , Hemosiderosis/prevención & control , Hepacivirus/efectos de los fármacos , Hepacivirus/genética , Hepatitis C Crónica/metabolismo , Hepatitis C Crónica/virología , Humanos , Irán , Masculino , ARN Viral/sangre , ARN Viral/efectos de los fármacos , Proteínas Recombinantes , Reacción a la Transfusión , Resultado del Tratamiento , Talasemia beta/sangre , Talasemia beta/terapiaRESUMEN
The seroprevalence of hepatitis E virus infection (HEV) in children and young adults was determined in a community-based survey in an area of northern Islamic Republic of Iran. Serum samples were taken from 1080 randomly selected apparently healthy 2-25-year-olds from urban and rural regions of Sari district. Anti-HEV IgG antibodies were detected in 25 individuals (2.3%). Seroprevalence increased significantly with age from 3/255 (1.2%) in children < 10 years to 8/110 (7.3%) in those aged 20-25 years. No differences in HEV status were noted between the sexes. Earlier age at exposure to infection and a higher infection rate were found in people residing in rural areas than in urban areas.
Asunto(s)
Enfermedades Endémicas/estadística & datos numéricos , Virus de la Hepatitis E , Hepatitis E/epidemiología , Adolescente , Adulto , Distribución por Edad , Anticuerpos Antivirales/sangre , Distribución de Chi-Cuadrado , Niño , Preescolar , Estudios Transversales , Femenino , Hepatitis E/sangre , Hepatitis E/inmunología , Virus de la Hepatitis E/inmunología , Humanos , Inmunoglobulina G/sangre , Irán/epidemiología , Masculino , Análisis Multivariante , Vigilancia de la Población , Factores de Riesgo , Salud Rural/estadística & datos numéricos , Estudios Seroepidemiológicos , Distribución por Sexo , Factores Socioeconómicos , Salud Urbana/estadística & datos numéricos , Adulto JovenAsunto(s)
Enfermedades Duodenales/diagnóstico , Hemorragia Gastrointestinal/diagnóstico , Hernia Abdominal/diagnóstico , Gastropatías/diagnóstico , Anciano , Diagnóstico Diferencial , Enfermedades Duodenales/complicaciones , Enfermedades Duodenales/cirugía , Femenino , Hemorragia Gastrointestinal/etiología , Hemorragia Gastrointestinal/cirugía , Hernia Abdominal/complicaciones , Hernia Abdominal/cirugía , Humanos , Gastropatías/complicaciones , Gastropatías/cirugíaRESUMEN
We conducted this study to determine the contribution of respiratory viruses in 202 hospitalized children (1 mo-5 yr) with clinical evidence of acute lower respiratory tract illness (ALRI). Nasopharyngeal specimens were assayed for viruses detection by indirect immunoflourescent method. Viral agents were identified from 109 (54%) cases (9 cases had dual infection). The most commonly detected virus was parainfluenza virus 3 in 32 (15.8%) cases followed by respiratory syncytial virus 26 (12.9%) parainfluenza 1 and parainfluenza 2 each 13 (6.4%) influenza A 16 (7.4%), influenza B; 7(3.5%), and adenovirus 12 (5.9%). There were no demographic, clinical, radiologic or laboratory parameters except for recurrent wheeze (OR: 4.47; (95% CI: 1.98-10.73) and fever (OR: 3.27; (95% CI: 1.73-6.20), which could differentiate between patients with or without viral etiology.
Asunto(s)
Pulmón/microbiología , Infecciones del Sistema Respiratorio , Antibacterianos/uso terapéutico , Áreas de Influencia de Salud , Preescolar , Femenino , Hospitalización , Humanos , Lactante , Irán/epidemiología , Masculino , Nasofaringe/microbiología , Infecciones por Paramyxoviridae/complicaciones , Infecciones por Paramyxoviridae/epidemiología , Infecciones por Paramyxoviridae/rehabilitación , Síndrome de Dificultad Respiratoria/epidemiología , Síndrome de Dificultad Respiratoria/microbiología , Síndrome de Dificultad Respiratoria/rehabilitación , Infecciones por Virus Sincitial Respiratorio/complicaciones , Infecciones por Virus Sincitial Respiratorio/epidemiología , Infecciones por Virus Sincitial Respiratorio/rehabilitación , Infecciones del Sistema Respiratorio/epidemiología , Infecciones del Sistema Respiratorio/microbiología , Infecciones del Sistema Respiratorio/rehabilitaciónRESUMEN
To determine the frequency and pattern of antibiotic susceptibility of uropathogens in urinary tract infection (UTI) from 3 university hospitals we carried out a retrospective review of urine culture and antibiotic sensitivity testing from symptomatic outpatients and inpatients during 2002-2003. Of 5600 samples, 703 (12.6%) were culture positive, 38.7% of which were from hospitalized patients. Escherichia coli was the leading cause of UTI in both groups of patients. The rates and roles of other pathogens, including Pseudomonas spp. (5.3%-10.4%), Enterobacter spp. (0%-5.7%), Staphylococcus spp.) 5.4%-26.4%), differed in each hospital. Differences in antibacterial susceptibility patterns were observed. Ampicillin (82%-100%) and co-trimoxazole (50%-90%) resistance were the most frequent. Methicillin resistance in Staphylococcus spp. ranged from 17% to 60%.
Asunto(s)
Infecciones Comunitarias Adquiridas/epidemiología , Infecciones Comunitarias Adquiridas/microbiología , Infección Hospitalaria/epidemiología , Infección Hospitalaria/microbiología , Infecciones Urinarias/epidemiología , Infecciones Urinarias/microbiología , Adulto , Distribución de Chi-Cuadrado , Niño , Infecciones Comunitarias Adquiridas/tratamiento farmacológico , Infección Hospitalaria/tratamiento farmacológico , Farmacorresistencia Bacteriana , Infecciones por Enterobacteriaceae/epidemiología , Infecciones por Escherichia coli/epidemiología , Femenino , Hospitales Universitarios , Humanos , Recién Nacido , Irán/epidemiología , Masculino , Pruebas de Sensibilidad Microbiana , Vigilancia de la Población , Infecciones por Pseudomonas/epidemiología , Estudios Retrospectivos , Factores de Riesgo , Distribución por Sexo , Infecciones Estafilocócicas/epidemiología , Urinálisis , Infecciones Urinarias/tratamiento farmacológicoRESUMEN
This study was designed to evaluate seroprevalence rates of antibodies to pertussis in mothers and their infants, and the immunogenicity of pertussis vaccine in the presence or absence of pertussis antibodies in infants. Blood samples were collected from 110 mother-infants pairs before the first dose of pertussis vaccination and from 69 infants 4-8 weeks after administration of the third dose of DTwP vaccine. Pertussis antibodies were >25 U/mL in 88(78.9%) mothers and 50(45.3%) infants with a mean titer of 67(SD 48.1) and 33.5 (34.7) U/mL, respectively. After administration of three doses of DTwP vaccine, 53(76.8%) infants were seroconverted (MCA titer 87.4 (51.3)U/mL. Immunologic response to vaccination was similar between the two groups of infants; 30/37 (81.1%) of seronegative infants and 23/32 (71.9%) of seropositive infants at pre-vaccination, showed seroconversion after the vaccination (P = 0.36). The results of this study demonstrated that most of the studied mothers were serologically immune to pertussis, and this immunity was transferred to their infants. Pre-vaccination antibody did not affect infants immune response to vaccination.
Asunto(s)
Anticuerpos Antibacterianos/sangre , Bordetella pertussis/inmunología , Vacuna contra Difteria, Tétanos y Tos Ferina/inmunología , Vacunación , Tos Ferina/prevención & control , Adulto , Vacuna contra Difteria, Tétanos y Tos Ferina/administración & dosificación , Femenino , Humanos , Inmunoglobulina G , Lactante , Proyectos Piloto , Estudios Seroepidemiológicos , Tos Ferina/sangre , Tos Ferina/inmunologíaRESUMEN
To determine the incidence and characteristics of measles, cases reported to the Health Center for Diseases Control 2000-2002 were reviewed. Demographics data, vaccination status and its relation to occurrence the disease were analysed. A total of 729 cases (270 women,162, 269, 298, over the 3 years) were reported. The annual incidence rates over the 3 years were 7.1, 11.9 and 12.7 for each 10(5) population. In full vaccinated subjects, 46.5% of the cases occurred and 39.9% of the cases had not been vaccinated. Because of the high incidence rate of measles both in vaccinated and unvaccinated individuals, paying more attention to proper shipping and storing of vaccine, and even catch-up immunization for increasing herd immunity are recommended.
Asunto(s)
Accesibilidad a los Servicios de Salud , Programas de Inmunización/estadística & datos numéricos , Vacuna Antisarampión/provisión & distribución , Sarampión/epidemiología , Sarampión/prevención & control , Adolescente , Adulto , Niño , Preescolar , Demografía , Femenino , Humanos , Incidencia , Lactante , Recién Nacido , Irán/epidemiología , Masculino , Sarampión/etiología , Servicios Preventivos de Salud , Gobierno EstatalRESUMEN
Portal biliopathy is due to compression of the common bile duct by varicose veins constituting portal cavernoma. Usually asymptomatic, it can occasionally be responsible for jaundice or cholangitis. We report a case of portal cavernoma secondary to pylephlebitis complicating acute appendicitis, followed eleven years later by occurrence of cholestatic jaundice. Diagnosis of portal biliopathy was done by imaging and confirmed by endoscopic retrograde cholangiography with insertion of a plastic stent into common bile duct. This stent was periodically changed and allowed regression of jaundice with a 3-year follow-up. Through a review of the literature, both clinical and therapeutic characteristics of portal biliopathy were studied.
Asunto(s)
Ictericia Obstructiva/etiología , Vena Porta , Várices/complicaciones , Adulto , Humanos , MasculinoAsunto(s)
Colon/fisiología , Tránsito Gastrointestinal/fisiología , Adulto , Factores de Edad , Análisis de Varianza , Distribución de Chi-Cuadrado , Colon/diagnóstico por imagen , Femenino , Humanos , Masculino , Persona de Mediana Edad , Radiografía , Valores de Referencia , Factores Sexuales , Túnez , Adulto JovenRESUMEN
OBJECTIVES: The prevalence of cholelithiasis is still unknown in Tunisia. The aim of this study was to assess the prevalence and selected risk factors of cholelithiasis METHODS: Two thousand citizens over the age of 19 in a small town in the center of Tunisia were evaluated. Following a structured interview of each subject, an ultrasound examination was performed. Height, weight and blood levels of glucose and cholesterol were determined by standard methods. RESULTS: The response rate was 56% (746 women and 377 men). Of the 1123 persons evaluated, 19 had undergone previous cholecystectomy. Crude prevalence of cholelithiasis was 4% (5.4% in women and 1% in men). Typical biliary colic was the only symptom significantly associated with cholelithiasis (specificity: 97.6%). Presence of gallstones was associated with age (P=0.02), sex (P=0. 00045) and multiparity (P<0.0002). Neither body mass index, diabetes mellitus or hypercholesterolemia were risk factors. CONCLUSION: The prevalence of cholelithiasis in central Tunisia is low. The risk factors are similar to those in occidental surveys.
Asunto(s)
Colelitiasis/epidemiología , Adulto , Anciano , Índice de Masa Corporal , Colelitiasis/diagnóstico por imagen , Complicaciones de la Diabetes , Femenino , Humanos , Hipercolesterolemia/complicaciones , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Factores de Riesgo , Túnez/epidemiología , UltrasonografíaRESUMEN
DIAGNOSIS AND PROGNOSIS: Antiphospholipids comprise a very heterogeneous group of auto-antibodies including anticardiolipids demonstrated by immunological methods and lupus anticoagulants detected by coagulation tests. Antiphospholipids are encountered in various conditions other than dysimmune disease and are frequently involved in thrombotic manifestations. We discuss here the implications of these antibodies in digestive tract diseases and present an analysis of their diagnostic and prognostic value for optimal therapeutic and monitoring approaches. CLINICAL MANIFESTATIONS: The risk of thrombosis is high in patients with cryptogenetic inflammatory bowel disease. The prevalence of antiphospholipid antibodies (AcAPL) is abnormally high in these patients, but their contribution to the development of thrombosis remains controversial. Patients with liver disease generally exhibit coagulation disorders, with paradoxical thrombotic manifestations. AcAPL are strongly implicated in the development of thrombosis, particularly in patients with alcoholic liver disease, hepatitis C, regenerative nodular hyperplasia, and cirrhosis, independently of the presence of an associated hepatocellular carcinoma. Antiphospholipid syndrome is considered to be the second leading cause of non-tumor-related Budd-Chiari syndrome, after myeproliferative syndromes. Likewise for portal or mesenteric vein thrombosis where antiphospholipid antibodies would be involved in the causal mechanism. UNDERLYING MECHANISMS: Due to the diversity of these antibodies, it is unlikely that a unique mechanism could explain all the different thrombotic manifestations associated with their presence.
Asunto(s)
Anticuerpos Antifosfolípidos , Síndrome Antifosfolípido , Enfermedades del Sistema Digestivo/inmunología , Adulto , Anticuerpos Anticardiolipina/análisis , Anticuerpos Anticardiolipina/inmunología , Anticuerpos Antifosfolípidos/análisis , Anticuerpos Antifosfolípidos/inmunología , Síndrome Antifosfolípido/diagnóstico , Síndrome Antifosfolípido/inmunología , Síndrome de Budd-Chiari/inmunología , Enfermedad Celíaca/inmunología , Colitis/inmunología , Colitis Ulcerosa/inmunología , Enfermedad de Crohn/inmunología , Ensayo de Inmunoadsorción Enzimática , Hiperplasia Nodular Focal/inmunología , Hepatitis C/inmunología , Hepatitis Alcohólica/inmunología , Humanos , Enfermedades Inflamatorias del Intestino/inmunología , Hígado/enzimología , Cirrosis Hepática/inmunología , Cirrosis Hepática Alcohólica/inmunología , Hepatopatías/inmunología , Trasplante de Hígado , Prevalencia , Factores de Riesgo , Trombosis/etiología , Trombosis/inmunologíaRESUMEN
This paper presents distribution of phosphorus (total P, organic and inorganic P) in the southern of Caspian Sea sediments where collected from four sampling stations in the summer 2009. Several forms of the phosphorus in sediment were separated and extracted according to sequential extraction method. Then extracted phosphorus in each fraction was determined by UV-Vis spectrophotometery. Five forms of phosphorus were studied (i) loosely sorbed phosphorus, (ii) ferric-iron-bound phosphorus, (iii) authigenic phosphorus, (iv) detrital phosphorus, and (v) organic phosphorus. The total P contents were ranged from 124.5 to 328.2 µg g(-1). It was found that more than 98% of the total P is inorganic phosphorus (IP). Among the four forms of IP, loosely bound P, P-Fe, P-detrital and P-authigenic distribution ranges were 2.70-17.31%, 10.00-44.79%, 0.40-1.70% and 48.35-83.48%, respectively. Result also showed that the most abundant forms of phosphorus were authigenic phosphorus. Relative abundances of other forms of phosphorus follow the order: P-Fe>loosely bound-P>organic P>detrital P.